Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Laboratory animal studies are used in a wide range of human health related research areas, such as basic biomedical research, drug research, experimental surgery and environmental health. The results of these studies can be used to inform decisions regarding clinical research in humans, for example the decision to proceed to clinical trials. If the research question relates to potential harms with no expectation of benefit (e.g., toxicology), studies in experimental animals may provide the only relevant or controlled data and directly inform clinical management decisions. Systematic reviews and meta-analyses are important tools to provide robust and informative evidence summaries of these animal studies. Rating how certain we are about the evidence could provide important information about the translational probability of findings in experimental animal studies to clinical practice and probably improve it. Evidence summaries and certainty in the evidence ratings could also be used (1) to support selection of interventions with best therapeutic potential to be tested in clinical trials, (2) to justify a regulatory decision limiting human exposure (to drug or toxin), or to (3) support decisions on the utility of further animal experiments. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach is the most widely used framework to rate the certainty in the evidence and strength of health care recommendations. Here we present how the GRADE approach could be used to rate the certainty in the evidence of preclinical animal studies in the context of therapeutic interventions. We also discuss the methodological challenges that we identified, and for which further work is needed. Examples are defining the importance of consistency within and across animal species and using GRADE's indirectness domain as a tool to predict translation from animal models to humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Considering the difference and the leading clinical research, the SYRCLE group developed a framework definition of preclinical PICO, where ‘Population’ includes animal species and strain and any method of inducing a disease model, and several outcomes can be considered [8].”
From PICO entity extraction for preclinical animal literature. (2022) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Self-citationGRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Self-citationGrading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Self-citationGRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285 · cited 1×
“The optimal application of GRADE requires an up-to-date and well-conducted SR of animal studies [18, 25].”
MethodSelf-citationImproving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Cochrane Handbook for Systematic Reviews of Interventions
Tarsilla, M. (2010) · Journal of MultiDisciplinary Evaluation · doi:10.56645/jmde.v6i14.284 · Cited by 5,178
SYRCLE’s risk of bias tool for animal studies
Hooijmans, C. R., Rovers, M. M., de Vries, R. B., Leenaars, M., Ritskes-Hoitinga, M., & Langendam, M. W. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-43 · Cited by 4,415 · cited 2×
“In the probiotics for pancreatitis example, risk of bias was assessed with SYRCLE’s risk of bias tool [4].”
MethodSelf-citation
Research works printed but not linked: 4
- RB de Vries, 2014, Updated version of the Embase search filter for animal studies, Lab Anim, 48, 88
- P Alonso-Coello, GRADE Evidence to Decision frameworks: 1. Introduction, BMJ
- P Alonso-Coello, GRADE Evidence to Decision frameworks: 2. Clinical practice guidelines, BMJ
- HJ Schunemann, 2012, [Diagnostic accuracy and linked evidence—testing the chain], Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen, 106, 153
Cited by
Brozek, J. L., Canelo-Aybar, C., Akl, E. A., Bowen, J. M., Bucher, J., Chiu, W. A., Cronin, M., Djulbegovic, B., Falavigna, M., Guyatt, G. H., et al. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.09.018 · Cited by 331
“It has been applied to rating the certainty of evidence for management interventions, health care— related tests and strategies [32,33], prognostic information [34], evidence from animal studies [35], use of resources and cost-effectiveness evaluations [36], and values and preferences [37,38].”
MethodSelf-citationDeep learning tools for advancing drug discovery and development
Nag, S., Baidya, A. T. K., Mandal, A., Mathew, A. T., Das, B., Devi, B., & Kumar, R. (2022) · 3 Biotech · doi:10.1007/s13205-022-03165-8 · Cited by 174
“The molecules with optimized ADMET properties are then further evaluated for their effectiveness using suitable animal models (Hooijmans et al. 2018).”
BackgroundThe (misleading) role of animal models in drug development
Härtung, T. (2024) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2024.1355044 · Cited by 116
Martínez-Calderón, J., Flores-Cortés, M., Morales‐Asencio, J. M., Fernández-Sánchez, M., & Luque-Suárez, A. (2020) · Journal of Orthopaedic and Sports Physical Therapy · doi:10.2519/jospt.2020.9319 · Cited by 109
Currie, G. L., Angel-Scott, H. N., Colvin, L., Cramond, F., Hair, K., Khandoker, L., Liao, J., Macleod, M. R., McCann, S., Morland, R., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000243 · Cited by 87
Self-citationHooijmans, C. R., Hlavica, M., Schuler, F. A. F., Good, N., Good, A., Baumgartner, L., Galeno, G., Schneider, M. P., Jung, T., de Vries, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-35734-4 · Cited by 72
Self-citationLeveraging machine learning models in evaluating ADMET properties for drug discovery and development
Magesh, V., Rao, G. C., Karthik, M. J., & Maddi, S. (2025) · ADMET & DMPK · doi:10.5599/admet.2772 · Cited by 91
Schünemann, H. J., Santesso, N., Vist, G. E., Cuello, C., Lotfi, T., Flottorp, S., Davoli, M., Mustafa, R., Meerpohl, J. J., Alonso-Coello, P., et al. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.05.030 · Cited by 57
Self-citationEffects of Antioxidant Intake on Fetal Development and Maternal/Neonatal Health during Pregnancy
Sebastiani, G., Navarro‐Tapia, E., Almeida-Toledano, L., Serra-Delgado, M., Paltrinieri, A. L., García‐Algar, Ó., & Andreu-Férnández, V. (2022) · Antioxidants · doi:10.3390/antiox11040648 · Cited by 74
“The quality of evidence was based on the GRADE approach (Grades of Recommendation, Assessment, Development and Evaluation), which describes four levels of quality: high, moderate, low and very low [21,22].”
MethodRecommendations for robust and reproducible preclinical research in personalised medicine
Fosse, V., Oldoni, E., Biétrix, F., Budillon, A., Daskalopoulos, E. P., Fratelli, M., Gerlach, B., Groenen, P. M. A., Hölter, S. M., Menon, J. M. L., et al. (2023) · BMC Medicine · doi:10.1186/s12916-022-02719-0 · Cited by 63
Self-citationPhysiological Responses Induced by Manual Therapy in Animal Models: A Scoping Review
Lima, C. R., Martins, D. F., & Reed, W. R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00430 · Cited by 62
“Animal studies are conducted in a variety of health-related areas, such as drug and biomedical research (Hooijmans et al., 2018), with the intent to provide greater knowledge regarding physiological mechanisms, biological effects, and doseresponse relationships of particular therapeutic interventions (Hackam and Redel…”
BackgroundAmbreen, S., Umar, M., Noor, A., Jain, H., & Ali, R. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117164 · Cited by 53
Biodegradable metals for bone fracture repair in animal models: a systematic review
Zhang, J., Shang, Z., Jiang, Y., Zhang, K., Li, X., Ma, M., Li, Y., & Ma, B. (2020) · Regenerative Biomaterials · doi:10.1093/rb/rbaa047 · Cited by 47
“Among many kinds of pre-clinical studies, animal studies are critical to evaluate safety and performance of biomaterials and related medical devices [43].”
BackgroundTherapeutic Effects of Catechins in Less Common Neurological and Neurodegenerative Disorders
Sebastiani, G., Almeida-Toledano, L., Serra-Delgado, M., Navarro‐Tapia, E., Sailer, S., Valverde, O., García‐Algar, Ó., & Andreu-Férnández, V. (2021) · Nutrients · doi:10.3390/nu13072232 · Cited by 52
“Quality of evidence was assessed using the Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) approach with four levels of quality: high, moderate, low, and very low [20,21].”
MethodA practical guide to preclinical systematic review and meta-analysis
Soliman, N., Rice, A. S. C., & Vollert, J. (2020) · Pain · doi:10.1097/j.pain.0000000000001974 · Cited by 44
“Internal validity is comprised ofmitigating a range of biases: selection, performance, detection, and attrition bias,(57) and quality assessments provide structured insight into whether the existing data are at risk of bias.(28,30,34) Concomitantly, SRs can also be used to inform study design, eg, optimal animal model…”
BackgroundPacchierotti, F., Ardoino, L., Benassi, B., Consales, C., Cordelli, E., Eleuteri, P., Marino, C., Sciortino, M., Brinkworth, M. H., Chen, G., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106806 · Cited by 47
Self-citationCordelli, E., Ardoino, L., Benassi, B., Consales, C., Eleuteri, P., Marino, C., Sciortino, M., Villani, P., Brinkworth, M. H., Chen, G., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108178 · Cited by 46
van Velzen, M., Dahan, J. D. C., van Dorp, E. L. A., Mogil, J. S., Hooijmans, C. R., & Dahan, A. (2021) · Pain · doi:10.1097/j.pain.0000000000002231 · Cited by 40
Self-citationCordelli, E., Ardoino, L., Benassi, B., Consales, C., Eleuteri, P., Marino, C., Sciortino, M., Villani, P., Brinkworth, M. H., Chen, G., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108509 · Cited by 43
Development of an Evidence-Based Risk Assessment Framework
Krewski, D. R., Saunders-Hastings, P., Baan, R. A., Barton-Maclaren, T. S., Browne, P., Chiu, W. A., Gwinn, M., Hartung, T., Kraft, A. D., Lam, J., et al. (2022) · ALTEX · doi:10.14573/altex.2004041 · Cited by 51
Nguyen, T., Purcell, E., Smith, M. J., Penny, T. R., Paton, M. C. B., Zhou, L., Jenkin, G., Miller, S., McDonald, C. A., & Malhotra, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054351 · Cited by 32
“As per the GRADE tool guidelines adapted for preclinical studies, initial quality of certainty was “high” due to included studies being randomized trials [77,78].”
MethodMevissen, M., Ducray, A., Ward, J. M., Kopp‐Schneider, A., McNamee, J. P., Wood, A., Rivero, T. M., & Straíf, K. (2025) · Environment International · doi:10.1016/j.envint.2025.109482 · Cited by 31
Martin, E., Lamba, N., Flucke, U. E., Verhoef, C. K., Coert, J. H., Versleijen‐Jonkers, Y. M. H., & Desar, I. M. E. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.04.007 · Cited by 33
PICO entity extraction for preclinical animal literature.
Wang, Q., Liao, J., Lapata, M., & Macleod, M. (2022) · Systematic Reviews · doi:10.1186/s13643-022-02074-4 · Cited by 29
Self-citationVillamor-Martínez, E., Hundscheid, T. M., Kramer, B. W. W., Hooijmans, C. R., & Villamor, E. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.578984 · Cited by 32
“One final limitation that is inherent to all preclinical studies is the so-termed indirectness, which is defined as “how well the results translate from animals to the clinical situation” (28).”
BackgroundSelf-citationImproving the conduct, reporting, and appraisal of animal research
Ritskes-Hoitinga, M. J., & Wever, K. E. (2018) · BMJ · doi:10.1136/bmj.j4935 · Cited by 32
Self-citationSystematic review and meta-analysis of preclinical studies
Ineichen, B. V., Held, U., Salanti, G., Macleod, M. R., & Wever, K. E. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00347-x · Cited by 32
“Originally designed for systematic reviews in medical research, the 27 items of the PRISMA statement are also applicable to preclinical systematic reviews.”
Self-citationMevissen, M., Ward, J. M., Kopp‐Schneider, A., McNamee, J. P., Wood, A., Rivero, T. M., Thayer, K. A., & Straíf, K. (2022) · Environment International · doi:10.1016/j.envint.2022.107106 · Cited by 28
Self-citationTechnological advances in preclinical meta-research
Bannach‐Brown, A., Hair, K., Bahor, Z., Soliman, N., Macleod, M. R., & Liao, J. (2021) · BMJ Open Science · doi:10.1136/bmjos-2020-100131 · Cited by 28
Self-citationHow our approaches to assessing benefits and harms can be improved
Sena, E., & Currie, G. (2019) · Animal Welfare · doi:10.7120/09627286.28.1.107 · Cited by 23
Self-citationSchipholt, I. J. L., Coppieters, M. W., Meijer, O. G., Tompra, N., de Vries, R. B. M., & Scholten-Peeters, G. G. M. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000927 · Cited by 29
Vaccari, C., Grotto, D., Pereira, T. D. V., de Camargo, J. L. V., & Lopes, L. C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255726 · Cited by 23
Duque-Quintero, M., Hooijmans, C. R., Hurowitz, A., Ahmed, A., Barris, B., Homberg, J. R., Hen, R., Harris, A. Z., Balsam, P. D., & Atsak, P. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104849 · Cited by 26
Self-citationPurcell, E., Nguyen, T., Smith, M. J., Penny, T. R., Paton, M. C. B., Zhou, L., Jenkin, G., Miller, S., McDonald, C., & Malhotra, A. K. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad006 · Cited by 23
Morgan, R. L., Beverly, B., Ghersi, D., Schünemann, H. J., Rooney, A. A., Whaley, P., Zhu, Y., & Thayer, K. A. (2019) · Environment International · doi:10.1016/j.envint.2019.04.016 · Cited by 24
“GRADE has also supported over 20 topic-specific project groups for further methods development and has seen growing interest in application of the GRADE methodology in contexts outside of healthcare, such as for preclinical animal studies, test accuracy, public health and coverage decisions (Schünemann et al., 2019; H…”
MethodSelf-citationHarrison‐Brown, M., Scholes, C. J., Hafsi, K., Marenah, M., Li, J., Hassan, F., Maffulli, N., & Murrell, W. (2019) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-019-1070-8 · Cited by 29
Kimmelman, J., Kane, P. B., Bicer, S., & Carlisle, B. G. (2024) · Med · doi:10.1016/j.medj.2024.07.014 · Cited by 30
Almeida, N. C. O. D. S., da Silva, F. R. P., Carneiro, A. L. B., Lima, É. S., Barcellos, J. F. M., & Furtado, S. C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259545 · Cited by 28
Archer, D. P., McCann, S., Walker, A. M., Premji, Z., Rogan, K. J., Hutton, M. J. H., & Gray, L. J. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.07.024 · Cited by 21
Preclinical in vivo models of fracture-related infection: a systematic review and critical appraisal
Vanvelk, N., Morgenstern, M., Moriarty, T. F., Richards, R. G., Nijs, S., & Metsemakers, W. (2018) · European Cells and Materials · doi:10.22203/ecm.v036a14 · Cited by 21
Lu, X., Cai, H., Li, Y. R., Zheng, X., Yun, J., Li, W., Geng, X., Kwon, J., & Jiang, H. B. (2022) · Bioinorganic Chemistry and Applications · doi:10.1155/2022/4529520 · Cited by 22
Ritskes-Hoitinga, M. J., & Pound, P. (2022) · Journal of the Royal Society of Medicine · doi:10.1177/01410768221093551 · Cited by 19
Self-citationMatta, K., Ploteau, S., Coumoul, X., Koual, M., Bizec, B. L., Antignac, J., & Cano-Sancho, G. (2019) · Environment International · doi:10.1016/j.envint.2018.12.063 · Cited by 21
“The 3-Tier approach proposed by the NTP/OHAT Handbook will be used to synthesise RoB evaluations across studies included in the same outcome.”
BackgroundInfluentialHooijmans, C. R., Draper, D., Ergün, M., & Scheffer, G. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-54152-8 · Cited by 18
Self-citationDeana, N. F., Alves, N., Zaror, C., del Sol, M., & Bagnato, V. S. (2021) · Photobiomodulation Photomedicine and Laser Surgery · doi:10.1089/photob.2020.4972 · Cited by 21
“11 Preclinical studies, which analyze the effectiveness of PBMT in the burn wound healing tend to use experimental animals, such as rats and mice, as they are cheap and easy to breed and manage.”
Modular (universal) CAR-T platforms in vivo: a comprehensive systematic review
Mohammad, A., Yurina, A., Simonyan, T., Chistyakov, D., Salman, R., Zornikova, K. V., Minina, E. P., & Васильевна, Б. А. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1409665 · Cited by 19
Peter, E. L., Mtewa, A. G., Nagendrappa, P. B., Kaligirwa, A., & Sesaazi, D. C. (2020) · Systematic Reviews · doi:10.1186/s13643-019-1265-4 · Cited by 18
“The rating of certainty will be done for each outcome by considering the risk of bias (as assessed by SYCLE’s RoB tool), inconsistency (as assessed by heterogeneity tests, confidence intervals, and P values), imprecision, publication bias, and indirectness [47].”
MethodDeveloping a database of systematic reviews of animal studies
Langendam, M. W., Magnuson, K., Williams, A. R., Walker, V. R., Howdeshell, K. L., Rooney, A. A., & Hooijmans, C. R. (2021) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2021.104940 · Cited by 16
Self-citationAl‐Shibani, N. (2022) · Cureus · doi:10.7759/cureus.21095 · Cited by 22
“The use of periodontitis-induced animal models in a clinical trial provides further insight into possible therapeutic and/or preventive effects and interaction with certain physiological environments and supports decisions about human clinical research, such as whether or not to proceed to clinical trials [42].”
BackgroundGrammatikopoulou, M. G., Tousinas, G., Balodimou, C., Anastasilakis, D. A., Gkiouras, K., Dardiotis, E., Evangeliou, A., Bogdanos, D. P., & Goulis, D. G. (2022) · Maturitas · doi:10.1016/j.maturitas.2022.06.001 · Cited by 18
Menon, J. M. L., Ritskes-Hoitinga, M. J., Pound, P., & van Oort, E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260619 · Cited by 16
“Previous research highlighted that (preclinical) SRs can play a useful role in this context as they can provide helpful information and insights for policy decision making and translation from preclinical to clinical studies [11,51,52].”
BackgroundSelf-citationZhou, Z., Yun, J., Li, J., Chen, Y., Duan, T., Wang, L., Han, J., Jiang, H. B., & Niu, G. (2023) · Biomedical Materials · doi:10.1088/1748-605x/acc99a · Cited by 18
“According to several clinical trials, animal studies are necessary to evaluate the effectiveness and safety of biomaterials [21].”
Aghayan, A. H., Mirazimi, Y., Fateh, K., Keshtkar, A., Rafiee, M., & Atashi, A. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10741-3 · Cited by 17
“The GRADE results also suggest that survival rate finding has high certainty of evidence [38].”
Peter, E. L., Nagendrappa, P. B., Kaligirwa, A., Ogwang, P. E., & Sesaazi, D. C. (2020) · Phytotherapy Research · doi:10.1002/ptr.6853 · Cited by 19
Animal models of osteoarthritis
Little, C. B., Zaki, S., Blaker, C. L., & Clarke, E. (2022) · Bone and Joint Research · doi:10.1302/2046-3758.118.bjr-2022-0217.r1 · Cited by 15
Topical Host-Modulating Therapy for Periodontal Regeneration: A Systematic Review and Meta-Analysis
Wang, B., Shao, J., Fu, J., Jansen, J. A., Walboomers, X. F., Hooijmans, C. R., van Luijk, J. A. K. R., & Yang, F. (2019) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2019.0184 · Cited by 14
“38 For all three outcomes, a relatively high level of between-study heterogeneity was observed.”
Self-citationHooijmans, C. R., Donders, R., Magnuson, K., Wever, K. E., Ergün, M., Rooney, A. A., Walker, V. R., & Langendam, M. W. (2022) · Research Synthesis Methods · doi:10.1002/jrsm.1578 · Cited by 13
Self-citationMaljaars, L. P., Bendaoud, S., Kastelein, A. W., Güler, Z., Hooijmans, C. R., & Roovers, J. (2022) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3357 · Cited by 14
“Although the number of studies was only high enough to assess the RoB for publication bias in the gastrointestinal tract, publication bias is expected in other groups as well (Hooijmans et al., 2018).”
BackgroundSelf-citationRamírez, L. M. N., Mehaffy, C., & Dobos, K. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1467016 · Cited by 15
Siafis, S., McCutcheon, R. A., Chiocchia, V., Ostinelli, E. G., Wright, S. L., Stansfield, C., Juma, D. O., Mantas, I., Howes, O. D., Rutigliano, G., et al. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.19866.1 · Cited by 11
“Assessment of the degree to which the characteristics of the included studies reflect the clinical setting (see above) 94–97 .”
BackgroundMethodSelf-citationZeng, F., Carrasco, G., Li, B., Sophocleous, A., & Idris, A. I. (2023) · Scientific Reports · doi:10.1038/s41598-023-31557-0 · Cited by 13
Jarabek, A. M., & Hines, D. E. (2019) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2019.09.001 · Cited by 13
Verhorstert, K. W. J., Gudde, A. N., Kortz, B. S., Limpens, J., Roovers, J., Hooijmans, C. R., & Güler, Z. (2021) · Neurourology and Urodynamics · doi:10.1002/nau.24677 · Cited by 12
Self-citationFaraone, S. V., Ward, C. L., Boucher, M., Elbekai, R., & Brunner, E. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106275 · Cited by 10
“Additional GRADE and Cochrane guidance was applied for non-clinical studies (Hooijmans et al., 2018; Soliman et al., 2020).”
Deana, N. F., Zaror, C., del Sol, M., Bagnato, V. S., & Alves, N. (2022) · Burns · doi:10.1016/j.burns.2022.05.009 · Cited by 11
Deckers, C., Stephan, P., Wever, K. E., Hooijmans, C. R., & Hannink, G. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.10.001 · Cited by 10
Self-citationPaskal, W., Gotowiec, M., Stachura, A., Kopka, M., & Wlodarski, P. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052622 · Cited by 9
“• VEGF gene delivery to the flap increases its survival regardless of flap type, gene method, or timing in an in vivo model.”
BackgroundYang, Y., Sun, Z., Sun, X., Zhang, J. C., Tong, T., Zhang, X., & Yao, K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1452545 · Cited by 9
“Frontiers in Pharmacology frontiersin.org the possibility of providing evidence for the potential translational value of animal models for humans (Hooijmans et al., 2018).”
BackgroundOliveira, G. E., Barbirato, D. D. S., de Oliveira, B. M., Fuly, M. S., Pelegrine, H. C. L., Bonilha, D. C., de Alencar, J. G. P., Theodoro, L. H., & de Molon, R. S. (2024) · BioMed Research International · doi:10.1155/bmri/1716735 · Cited by 10
“They aid in hypothesis validation and demonstrate the e ff ectiveness of new treatment therapies, thereby supporting decisions regarding human clinical research [88, 89].”
Hazrati, P., Azadi, A., Fekrazad, S., Wang, H., & Fekrazad, R. (2025) · Lasers in Medical Science · doi:10.1007/s10103-025-04376-0 · Cited by 10
“To evaluate the certainty of the evidence, two reviewers (PH and AA) applied the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) tool for preclinical animal intervention studies [9].”
Sophocleous, A., Yiallourides, M., Zeng, F., Pantelas, P., Stylianou, E., Li, B., Carrasco, G., & Idris, A. I. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105928 · Cited by 9
Value of preclinical systematic reviews and meta-analyses in pediatric research
Romantsik, O., Bank, M., Menon, J. M. L., Malhotra, A. K., & Bruschettini, M. (2024) · Pediatric Research · doi:10.1038/s41390-024-03197-1 · Cited by 11
Hogue, O., Harvey, T., Crozier, D., Sonneborn, C., Postle, A. F., Block‐Beach, H., Somasundaram, E. V., May, F. J., Braun, M. S., Pasadyn, F. L., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265154 · Cited by 9
Grotto, D., Camargo, I. F., Kodaira, K., Mazzei, L. G., Castro, J., Vieira, R. A. L., Bergamaschi, C. D. C., & Lopes, L. C. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1205-3 · Cited by 8
Zeng, F., Wade, A., Harbert, K., Patel, S., Holley, J. S., Dehghanpuor, C. K., Hopwood, T. W., Marino, S., Sophocleous, A., & Idris, A. I. (2024) · Scientific Reports · doi:10.1038/s41598-024-56220-0 · Cited by 10
Umbilical cord blood-derived therapy for preterm lung injury: a systematic review and meta-analysis
Purcell, E., Shah, J., Powell, C., Nguyen, T., Zhou, L., McDonald, C., Allison, B. J., & Malhotra, A. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae033 · Cited by 6
“37,38”
Shojaei‐Zarghani, S., Fattahi, M. R., Kazemi, A., & Safarpour, A. R. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105206 · Cited by 9
Malignant Peripheral Nerve Sheath Tumors: Balancing oncological and functional outcomes
Martin, E. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/462 · Cited by 7
Animal Models in Neuroscience: What Is the “Culture of Care”?
Montanari, M., Bonsi, P., Martella, G., & Wirz, A. (2024) · Encyclopedia · doi:10.3390/encyclopedia4010018 · Cited by 11
Cao, S., Wei, Y., Qi, T., Xiong, A., Liu, P., Chen, Y., Zeng, H., Yu, F., & Weng, J. (2023) · Muscle & Nerve · doi:10.1002/mus.28018 · Cited by 7
“65 Finally, the inclusion of published studies and the exclusion of non-English studies may give rise to selection bias.”
BackgroundJansson, P. M., Lynggaard, C. D., Carlander, A. F., Jensen, S. B., Follin, B., Hoeeg, C., Kousholt, B. S., Larsen, R. T., Grønhøj, C., Jakobsen, K. K., et al. (2022) · Systematic Reviews · doi:10.1186/s13643-022-01943-2 · Cited by 6
Rossetti, B. R., Lemos, A. F., Só, B. B., Weissheimer, T., Martins, M. D., & Só, M. V. R. (2022) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2022.105496 · Cited by 8
Ostinelli, E. G., Chiocchia, V., Macleod, M. R., Browning, M. D., Harmer, C. J., Siafis, S., Stansfield, C., Friedrich, C., Wright, S. L., Chikaura, T., et al. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.19870.1 · Cited by 6
Self-citationGap Analysis of Swine-Based Hemostasis Research: “Houses of Brick or Mansions of Straw?”
Reynolds, P. S., & Garvan, C. S. (2020) · Military Medicine · doi:10.1093/milmed/usz249 · Cited by 7
Duranté, E. K., Ribeiro, A., Gaspard-Boulinc, L., Boutron, I., Henry, C., Petit, A., Houenou, J., Lemogne, C., & Chevance, A. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2024.292 · Cited by 8
“87,88 Limitations Our study has several limitations.”
van der Pol, A., Peters, M. M. C., Jorba, I., Smits, A. M., van der Kaaij, N. P., Goumans, M., Wever, K. E., & Bouten, C. V. C. (2025) · Communications Medicine · doi:10.1038/s43856-025-00812-y · Cited by 5
“To summarize our con fi dence in the evidence discussed in this systematic review, we applied the draft pre-clinical GRADE approach to all outcomes (Table 2) 35 .”
Self-citationFaraone, S. V., Ward, C. L., Boucher, M., Elbekai, R. H., & Brunner, E. (2025) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2025.2552324 · Cited by 10
“Additional GRADE and Cochrane guidance was considered for nonclinical studies [26,27].”
Pistollato, F., Furtmann, F., Straccia, M., Avey, M. T., Azilagbetor, D. M., Camp, C., Delaney, C. P., Ferreira, G. S., García‐Bermejo, L., Gastaldello, A., et al. (2025) · Alternatives to Laboratory Animals · doi:10.1177/02611929251398821 · Cited by 5
“In the fi nal segment of the joint presentation, Simon Lohse (Radboud University) introduced and critically assessed the GRADE4Animals framework, 25 a recently developed methodological adaptation of the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach, 40 tailored…”
Self-citationTeixeira, C. D., Barbosa, P. O., & de Souza, M. O. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105944 · Cited by 5
Nigussie, D., Legesse, B. A., Davey, G., Fekadu, A., & Makonnen, E. (2020) · BMJ Open Science · doi:10.1136/bmjos-2020-100064 · Cited by 6
Korczeniewska, O. A., Kohli, D., Rider, G. K., Zaror, C., Iturriaga, V., & Benoliel, R. (2021) · European Journal Of Oral Sciences · doi:10.1111/eos.12786 · Cited by 5
Salazar-González, H., Gutiérrez-Mercado, Y. K., Munguía-Galaviz, F. J., & Echavarría, R. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9050132 · Cited by 6
Artificial Intelligence in Dermatology Research and Drug Discovery
Utti, V., Bikias, T., Agarwal, A. A., Bikia, V., Zhou, A. Y., Shah, M. M., & Daneshjou, R. (2025) · Dermatologic Clinics · doi:10.1016/j.det.2025.05.008 · Cited by 6
Hogue, O., Zelinsky, M., Sonneborn, C., Anantasagar, T., Tumma, S., Genuario, I., Prabhakar, T., Smith, E., Adebulu, J., Salvaterra, M., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000214250 · Cited by 5
Chevitarese, A. B., Leite, K. L. D. F., Marañón‐Vásquez, G. A., Masterson, D., Pithon, M. M., & Maia, L. C. (2022) · Acta Odontologica Scandinavica · doi:10.1080/00016357.2022.2032329 · Cited by 4
Alves, N., Zaror, C., del Sol, M., Bagnato, V. S., & Deana, N. F. (2022) · International Journal of Morphology · doi:10.4067/s0717-95022022000100194 · Cited by 7
de Oliveira, A. V., Sampaio, A. L. N., Junior, R. W. M., & Andriolo, R. B. (2024) · Andrology · doi:10.1111/andr.13785 · Cited by 5
Weissheimer, T., Bischoff, K. F., Troian-Michel, C. H., Só, B. B., Martins, M. D., Souza, M. A., da Rosa, R. A., & Só, M. V. R. (2023) · Restorative Dentistry & Endodontics · doi:10.5395/rde.2023.48.e24 · Cited by 5
Qodir, N., Legiran, L., Hafy, Z., Pramuditho, D., Iman, M. B., Syafira, F., Deanasa, R. S., & Afladhanti, P. M. (2025) · Journal of Clinical Medicine Research · doi:10.14740/jocmr6230 · Cited by 3
“Furthermore, the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) Working Group’s Guideline Development Tool (GRADEpro GDT) was utilized [26, 27].”
Espósito, L. M. B., da Rocha, F. C., Arany, P. R., & Ferraresi, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14196716 · Cited by 3
“Specific recommendations were followed for grading the preclinical animal intervention studies [25].”
Metadata
- Authors
- Hooijmans, C. R., de Vries, R. B. M., Ritskes-Hoitinga, M., Rovers, M. M., Leeflang, M. M., IntHout, J., Wever, K. E., Hooft, L., de Beer, H., Kuijpers, T., Macleod, M. R., Sena, E. S., ter Riet, G., Morgan, R. L., Thayer, K. A., Rooney, A. A., Guyatt, G. H., Schünemann, H. J., Langendam, M. W., & on behalf of the GRADE Working Group
- Affiliations
- Radboud University Medical Center (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- University Medical Center Utrecht (NL)
- Dutch College of General Practitioners (NL)
- University of Edinburgh (GB)
- McMaster University (CA)
- United States Department of Health and Human Services (US)
- Corresponding author
- Langendam, Miranda W.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-01-11
- Volume
- 13
- Issue
- 1
- Pages
- e0187271
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5764235
- OpenAlex
- W2784327403
- Cited by
- 176
- References
- 60
- Citations by year
- 2026: 45 · 2025: 23 · 2024: 22 · 2023: 17 · 2022: 24 · 2021: 15 · 2020: 13 · 2019: 13 · 2018: 4
- FWCI
- 8.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Figshare (submittedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- Ministerie van Volksgezondheid, Welzijn en Sport (321200)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- preclinical animal studies, GRADE, translational research, animal-to-human extrapolation, indirectness, toxicology, evidence-based medicine
- MeSH terms
- Animals, Decision Making, Delivery of Health Care, Humans, Evidence-Based Medicine, Models, Animal, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.